Literature DB >> 24564348

Nanotechnology: a magic bullet for HIV AIDS treatment.

Lalit Kumar1, Shivani Verma, Deo Nandan Prasad, Ankur Bhardwaj, Bhuvaneshwar Vaidya, Amit Kumar Jain.   

Abstract

Human immunodeficiency virus (HIV) infection has become devastating in last a few years. Nearly 7400 new infection cases are coming every day. Highly active antiretroviral therapy (HAART), which involves combination of at least three antiretroviral (ARV) drugs, has been used to extend the life span of the HIV-infected patients. HAART has played an important role to reduce mortality rate in the developed countries but in the developing countries condition is still worst with millions of people being infected by this disease. For the improvement of the situation, nanotechnology-based drug system has been explored for the HIV therapeutics. Nanosystems used for HIV therapeutics offer some unique advantage like enhancement of bioavailability, water solubility, stability, and targeting ability of ARV drugs. Main nanotechnology-based systems explored for HIV therapeutics are liposomes, nanoparticles, niosomes, polymeric micelles, and dendrimers. Present manuscript reviews conventional method of HIV therapeutics and recent advances in the field of nanotechnology-based systems for treatment of HIV-AIDS.

Entities:  

Keywords:  HAART; HIV; dendrimers; nanoparticles; nanotechnology

Mesh:

Substances:

Year:  2014        PMID: 24564348     DOI: 10.3109/21691401.2014.883400

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  11 in total

Review 1.  The role of nanotechnology in the treatment of viral infections.

Authors:  Lavanya Singh; Hendrik G Kruger; Glenn E M Maguire; Thavendran Govender; Raveen Parboosing
Journal:  Ther Adv Infect Dis       Date:  2017-07-05

2.  Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.

Authors:  Dongwei Guo; Gang Zhang; Tadeusz A Wysocki; Beata J Wysocki; Harris A Gelbard; Xin-Ming Liu; JoEllyn M McMillan; Howard E Gendelman
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine.

Authors:  Dongwei Guo; Tian Zhou; Mariluz Araínga; Diana Palandri; Nagsen Gautam; Tatiana Bronich; Yazen Alnouti; JoEllyn McMillan; Benson Edagwa; Howard E Gendelman
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

Review 4.  Harnessing nanostructured systems for improved treatment and prevention of HIV disease.

Authors:  Maya Monroe; Charles Flexner; Honggang Cui
Journal:  Bioeng Transl Med       Date:  2018-07-27

5.  Highly active antiretroviral therapy-silver nanoparticle conjugate interacts with neuronal and glial cells and alleviates anxiety-like behaviour in streptozotocin-induced diabetic rats.

Authors:  Sodiq Kolawole Lawal; Samuel Oluwaseun Olojede; Ayobami Dare; Oluwaseun Samuel Faborode; Sheu Oluwadare Sulaiman; Edwin Coleridge Naidu; Carmen Olivia Rennie; Onyemaechi Okpara Azu
Journal:  IBRO Neurosci Rep       Date:  2022-06-16

Review 6.  Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs.

Authors:  Leila Fotooh Abadi; Fouad Damiri; Mehrukh Zehravi; Rohit Joshi; Rohan Pai; Mohammed Berrada; Ehab El Sayed Massoud; Md Habibur Rahman; Satish Rojekar; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-29       Impact factor: 4.967

7.  Tenofovir-silver nanoparticles conjugate ameliorates neurocognitive disorders and protects ultrastructural and cytoarchitectonic properties of the prefrontal cortex in diabetic rats.

Authors:  Sodiq Lawal; Samuel Oluwaseun Olojede; Sheu Oluwadare Sulaiman; Okikioluwa Stephen Aladeyelu; Roshila Moodley; Edwin C Stephen Naidu; Carmen Olivia Rennie; Onyemaechi Okpara Azu
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

8.  Activation of HIV-1 with Nanoparticle-Packaged Small-Molecule Protein Phosphatase-1-Targeting Compound.

Authors:  Kahli A Smith; Xionghao Lin; Oleg Bolshakov; James Griffin; Xiaomei Niu; Dmytro Kovalskyy; Andrey Ivanov; Marina Jerebtsova; Robert E Taylor; Emmanuel Akala; Sergei Nekhai
Journal:  Sci Pharm       Date:  2015-06-22

Review 9.  Nanosystems Applied to HIV Infection: Prevention and Treatments.

Authors:  Micaela A Macchione; Dariana Aristizabal Bedoya; Francisco N Figueroa; María Ángeles Muñoz-Fernández; Miriam C Strumia
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

Review 10.  Recent advances in siRNA delivery mediated by lipid-based nanoparticles.

Authors:  Sei Yonezawa; Hiroyuki Koide; Tomohiro Asai
Journal:  Adv Drug Deliv Rev       Date:  2020-08-06       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.